RESULTS OF MUTATIONAL STATUS OF IMMUNOGLOBULIN HEAVY‐CHAIN VARIABLE GENES ANALYSIS IN A COHORT OF PATIENTS WITH B‐CLL. A SINGLE CENTRE EXPERIENCE by Mardaraz, C., Sackmann, F., Pavlovsky, C., Pavlovsky, M., Zerga, M., Mela Osorio, M., Bullorsky, E., Pavlovsky, A.

Get full text

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E2, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and breast c... by HONEGGER, A. E, HOFER, E. L, BARANAO, R. I, MACKINLAY, T. A, MACKINLAY, D. A, BULLORSKY, E. O, BORDENAVE, R. H, CHASSEING, N. A

Get full text

Bone marrow fibroblastic progenitors in patients with advanced breast cancer by CHASSEING, N. A, TREJO, Y. G, BORDENAVE, R. H, BULLORSKY, E. O, DIAZ, N. B, RUMI, L. S

Get full text

Fibroblastic colony‐forming units and levels of tumor necrosis factor and prostaglandin E2 in bone marrow cultures from patients with advanced lung carcinoma by Chasseing, Norma A., Bordenave, Raul H., Bullorsky, Eduardo O., Diaz, Norma B., Stemmelin, German R., Rumi, Lia S.

Get full text

Treatment with cyclosporin A cream for the cutaneous reactions associated with imatinib therapy by Schamun, Alejandro, Bullorsky, Eduardo, Stemmelin, German, Saxton, Ricardo, Ricchione, Daniel

Get full text

Megadose methylprednisolone or IVIG for idiopathic thrombocytopenic purpura by Stemmelin, G.R., Shanley, C.M., Ceresetto, J.M., Bullorsky, E.O.

Get full text

True, True and Related? by Ebner, Roberto, DaCol, Elida, Bullorsky, Eduardo

Get full text

Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients by de Cavanagh, Elena M. V., Honegger, Alba E., Hofer, Erica, Bordenave, Raul H., Bullorsky, Eduardo O., Chasseing, Norma A., Fraga, Cesar

Get full text

Interleukin-1 beta, transforming growth factor beta 1, prostaglandin E^sub 2^, and fibronectin levels in the conditioned mediums of bone marrow fibroblast cultures from lung and br... by Honegger, A, Hofer, E, Barañao, R, Mackinlay, T, Mackinlay, D, Bullorsky, E, Bordenave, R, Chasseing, N

Get full text

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts by Abboud, Camille, Berman, Ellin, Cohen, Adam, Cortes, Jorge, DeAngelo, Daniel, Deininger, Michael, Devine, Steven, Druker, Brian, Fathi, Amir, Jabbour, Elias, Jagasia, Madan, Kantarjian, Hagop, Khoury, Jean, Laneuville, Pierre, Larson, Richard, Lipton, Jeffrey, Moore, Joseph O., Mughal, Tariq, O’Brien, Susan, Pinilla-Ibarz, Javier, Quintas-Cardama, Alfonso, Radich, Jerald, Reddy, Vishnu, Schiffer, Charles, Shah, Neil, Shami, Paul, Silver, Richard T., Snyder, David, Stone, Richard, Talpaz, Moshe, Tefferi, Ayalew, Van Etten, Richard A., Wetzler, Meir, Abruzzese, Elisabetta, Apperley, Jane, Breccia, Massimo, Byrne, Jenny, Cervantes, Francisco, Chelysheva, Ekaterina, Clark, R. E., de Lavallade, Hugues, Dyagil, Iryna, Gambacorti-Passerini, Carlo, Goldman, John, Haznedaroglu, Ibrahim, Hjorth-Hansen, Henrik, Holyoake, Tessa, Huntly, Brian, le Coutre, Philipp, Lomaia, Elza, Mahon, Francois-Xavier, Marin-Costa, David, Martinelli, Giovanni, Mayer, Jiri, Milojkovic, Dragana, Olavarria, Eduardo, Porkka, Kimmo, Richter, Johan, Rousselot, Philippe, Saglio, Giuseppe, Saydam, Guray, Stentoft, Jesper, Turkina, Anna, Vigneri, Paolo, Zaritskey, Andrey, Aguayo, Alvaro, Ayala, Manuel, Bendit, Israel, Maria Bengio, Raquel, Best, Carlos, Bullorsky, Eduardo, Cervera, Eduardo, DeSouza, Carmino, Fanilla, Ernesto, Gomez-Almaguer, David, Hamerschlak, Nelson, Lopez, Jose, Magarinos, Alicia, Meillon, Luis, Milone, Jorge, Moiraghi, Beatriz, Pasquini, Ricardo, Pavlovsky, Carolina, Ruiz-Arguelles, Guillermo J., Spector, Nelson, Arthur, Christopher, Browett, Peter, Grigg, Andrew, Hu, Jianda, Huang, Xiao-jun, Hughes, Tim, Jiang, Qian, Jootar, Saengsuree, Kim, Dong-Wook, Malhotra, Hemant, Malhotra, Pankaj, Matsumura, Itaru, Melo, Junia, Ohnishi, Kazunori

Get full text

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplasti... by Schrezenmeier, Hubert, Passweg, Jakob R., Marsh, Judith C.W., Bacigalupo, Andrea, Bredeson, Christopher N., Bullorsky, Eduardo, Camitta, Bruce M., Champlin, Richard E., Gale, Robert Peter, Fuhrer, Monika, Klein, John P., Locasciulli, Anna, Oneto, Rosi, Schattenberg, Antonius V.M.B., Socie, Gerard, Eapen, Mary

Get full text

Long-term efficacy and safety of dasatinib in patients with chronic myeloid leukemia in accelerated phase who are resistant to or intolerant of imatinib by Ottmann, Oliver, Saglio, Giuseppe, Apperley, Jane F., Arthur, Christopher, Bullorsky, Eduardo, Charbonnier, Aude, Dipersio, John F., Kantarjian, Hagop, Khoury, Hanna Jean, Kim, Dong-Wook, Healey, Diane, Strauss, Lewis, Cortes, Jorge E.

Get full text

Switching To Nilotinib In Patients (pts) With Chronic Myeloid Leukemia In Chronic Phase (CML-CP) With Suboptimal Cytogenetic Response (CyR) On Imatinib: First Results Of The LASOR... by Cortes, Jorge E., Antonio De Souza, Carmino, Lopez, Jose Luis, Ayala, Manuel, Bullorsky, Eduardo, Huang, Xiaojun, Shah, Sandip, Babu, K. Govind, Sacha, Tomasz, Bendit, Israel, Liang, Zhizhou, Owugah, Tina, Nidamarthy, Prasanna Kumar, Szczudlo, Tomasz, Piccolo, Carmen, le Coutre, Philipp D.

Get full text

Bosutinib As Therapy for Chronic Phase Chronic Myeloid Leukemia Following Failure with Imatinib Plus Dasatinib and/or Nilotinib: 24-Month Minimum Follow-up Update by Khoury, H. Jean, Gambacorti-Passerini, Carlo, Kantarjian, Hagop M., Kim, Dong-Wook, Marin, David, Dorlhiac-Llacer, Pedro E, Zaritskey, Andrey, Navarro, Juan, Bullorsky, Eduardo O, Assouline, Sarit, Leip, Eric, Kelly, Virginia, Turnbull, Kathleen, Besson, Nadine, Cortes, Jorge E

Get full text

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study by Bengió, Raquel M., Riva, Maria E., Moiraghi, Beatriz, Lanari, Emilio, Milone, Jorge, Ventriglia, Veronica, Bullorsky, Eduardo, Tezanos pinto, Miguel de, Murro, Hector, Bianchini, Michele, Larripa, Irene

Get full text

Cross-sectional study of adherence to venous thromboembolism prophylaxis guidelines in hospitalized patients. The Trombo-Brit study by Bottaro, Federico Jorge, Ceresetto, José Manuel, Emery, John, Bruetman, Julio, Emery, Nicholas, Pellegrini, Débora, Pinoni, Victoria, Piñeiro, Gastón, Fox, Laura, Orrico, María Eugenia, Palmer, Silvina, Prieto, Sebastián, Bullorsky, Eduardo

Get full text

Hemophagocytic syndrome. Report of four cases by Young, Pablo, Peroni, Jose, Finn, Bárbara C, Venditti, Julio E, Preiti, Verónica, Bullorsky, Eduardo, Bruetman, Julio E

Get full text

Síndrome hematofagocítico: Reporte de cuatro casos y revisión de la literatura by YOUNG, PABLO, PERONI, JOSE, FINN, BÁRBARA C, VENDITTI, JULIO E, PREITI, VERÓNICA, BULLORSKY, EDUARDO, BRUETMAN, JULIO E

Get full text

Dasatinib induces significant hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase. Commentary by GUILHOT, Francois, APPERLEY, Jane, HEIM, Dominik, LARSON, Richard A, BRANFORD, Susan, MULLER, Martin C, AGARWAL, Prasheen, GOLLERKERI, Ashwin, TALPAZ, Moshe, O'BRIEN, Stephen, KIM, Dong-Wook, BULLORSKY, Eduardo O, BACCARANI, Michele, ROBOZ, Gail J, AMADORI, Sergio, DE SOUZA, Carmino A, LIPTON, Jeffrey H, HOCHHAUS, Andreas

Get full text

Síndrome hematofagocítico: Reporte de cuatro casos y revisión de la literatura by YOUNG, PABLO, PERONI, JOSE, FINN, BÁRBARA C, VENDITTI, JULIO E, PREITI, VERÓNICA, BULLORSKY, EDUARDO, BRUETMAN, JULIO E

Get full text